发明申请
- 专利标题： Compounds Which Selectively Modulate The CB2 Receptor
- 专利标题（中）： 选择性调节CB2受体的化合物
-
申请号： US12564132申请日： 2009-09-22
-
公开(公告)号： US20100081644A1公开(公告)日： 2010-04-01
- 发明人: Alessandra BARTOLOZZI , Angela BERRY , Eugene Richard HICKEY , Markus OSTERMEIER , Doris RIETHER , Achim SAUER , David Smith THOMSON , Lifen WU , Renee M. ZINDELL , Patricia AMOUZEGH , Nigel James BLUMIRE , Stephen Peter EAST , Monika ERMANN , Someina KHOR , Innocent MUSHI
- 申请人： Alessandra BARTOLOZZI , Angela BERRY , Eugene Richard HICKEY , Markus OSTERMEIER , Doris RIETHER , Achim SAUER , David Smith THOMSON , Lifen WU , Renee M. ZINDELL , Patricia AMOUZEGH , Nigel James BLUMIRE , Stephen Peter EAST , Monika ERMANN , Someina KHOR , Innocent MUSHI
- 申请人地址： DE Ingelheim am Rhein
- 专利权人： Boehringer Ingelheim International GmbH
- 当前专利权人： Boehringer Ingelheim International GmbH
- 当前专利权人地址： DE Ingelheim am Rhein
- 主分类号： A61K31/4196
- IPC分类号： A61K31/4196 ; C07D413/12 ; A61K31/422 ; C07D417/12 ; A61K31/41 ; A61K31/454 ; C07D249/14
摘要：
Compounds of formula (I) are disclosed. Compounds according to the invention bind to and are agonists, antagonists or inverse agonists of the CB2 receptor, and are useful for treating inflammation. Those compounds which are agonists are additionally useful for treating pain.
公开/授权文献
- US08048899B2 Compounds which selectively modulate the CB2 receptor 公开/授权日：2011-11-01
信息查询
